Actuate Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Actuate Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ACTU
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001652935
Board of directors
-
Aaron G.l. Fletcher · DirectorSince 2024
-
Amy L. Ronneberg · DirectorSince 2024
-
Dan Zabrowski · DirectorSince 2024
-
Daniel M. Schmitt · Director · President, CEO and DirectorSince 2024
-
Jason A. Keyes · DirectorSince 2024
-
Roger Sawhney · DirectorSince 2024
-
Todd S. Thomson · DirectorSince 2024
Chief executives
Daniel M. Schmitt
· President, CEO and Director
Since August 2024
Board connections
1 of this board's directors also sit on 2 other boards.
- via Aaron G.l. Fletcher
- via Aaron G.l. Fletcher
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2024 | Kairos-Actuate SPV, L.P. Director, 1.5% Owner | Derivative conversion | +1,058,318 | — | — |
| Aug 14, 2024 | BP Directors, LP Director, 10% owner | Derivative conversion | +884,427 | — | — |
| Aug 14, 2024 | BIOS Equity Partners III, LP Director, 10% owner | Derivative conversion | +884,427 | — | — |
| Aug 14, 2024 | BIOS Fund II QP, LP Director, 10% owner | Derivative conversion | +884,427 | — | — |
| Aug 14, 2024 | Kairos-Actuate SPV, L.P. Director, 1.5% Owner | Derivative conversion | +726,163 | — | — |
| Aug 14, 2024 | BP Directors, LP Director, 10% owner | Open-market purchase | +375,000 | $8.00 | $3,000,000 |
| Aug 14, 2024 | BIOS Equity Partners III, LP Director, 10% owner | Open-market purchase | +375,000 | $8.00 | $3,000,000 |
| Aug 14, 2024 | BIOS Fund II QP, LP Director, 10% owner | Open-market purchase | +375,000 | $8.00 | $3,000,000 |
| Aug 14, 2024 | Kairos-Actuate SPV, L.P. Director, 1.5% Owner | Derivative conversion | +69,445 | — | — |
| Aug 14, 2024 | BP Directors, LP Director, 10% owner | Open-market purchase | +125,000 | $8.00 | $1,000,000 |
| Aug 14, 2024 | BIOS Equity Partners III, LP Director, 10% owner | Open-market purchase | +125,000 | $8.00 | $1,000,000 |
| Aug 14, 2024 | BIOS Fund II QP, LP Director, 10% owner | Open-market purchase | +125,000 | $8.00 | $1,000,000 |
| Aug 14, 2024 | Kairos-Actuate SPV, L.P. Director, 1.5% Owner | Derivative conversion | +146,870 | — | — |
| Aug 14, 2024 | BP Directors, LP Director, 10% owner | Derivative conversion | +525,797 | — | — |
| Aug 14, 2024 | BIOS Equity Partners III, LP Director, 10% owner | Derivative conversion | +525,797 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.